<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 10/09/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 10/09/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">RAUL GARCIA</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">August 30, 1951 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>14611 SW 124TH PLACE<br/>MIAMI, FL 33186, US<br/><br/>Work Phone:  305-302-2898<br/>Primary Home Phone:  305-310-0625<br/>Mobile Phone:  305-310-0625<br/>Email:  rgdddg@gmail.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">75377 2.16.840.1.113883.4.391.329324<br/>75377 2.16.840.1.113883.4.391.329324.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">cc2080cb-6f0a-441c-90c0-81c378234238 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">November 22, 2024, 12:02:31, EST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">MICHAEL CAVANAUGH</td></tr><tr><td class="td_header_role_value internal_format">11211 SW 152ND ST<br/>MIAMI, FL 33157-1101, US<br/><br/>Tel:  305-255-1355<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">1440343 2.16.840.1.113883.4.391.329324</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From October 9, 2024, 13:20:00   to October 9, 2024, 13:40:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.329324</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">MICHAEL CAVANAUGH</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">11211 SW 152ND ST<br/>MIAMI, FL 33157-1101, US<br/><br/>Tel:  305-255-1355<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">RAUL GARCIA<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  305-310-0625<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">MICHAEL CAVANAUGH signed at October 9, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">11211 SW 152ND ST<br/>MIAMI, FL 33157-1101, US<br/><br/>Tel:  305-255-1355<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">ClareMedica Corporate SDPC</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">14750 NW 77th court suite 100<br/>MIAMI LAKES, FL 330161507, US<br/><br/>Tel:  786-485-1005<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Reason For Referral</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Procedures</a></li><li><a href="#id8">Encounters</a></li><li><a href="#id9">Assessments</a></li><li><a href="#id10">Plan Of Treatment</a></li><li><a href="#id11">Progress Notes</a></li><li><a href="#id12">History and Physical Notes</a></li><li><a href="#id13">Consultation Request Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1"/><td>Prednisone  (10.00000 - mg) (uncoded)</td><td ID="reaction1">Unknown</td><td>Allergy</td><td>01/08/2020</td><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>dr lingante at baptisrt hehas anappointmenon on 10/17/24 | for mri.</td></tr><tr><th>Diagnosis 1</th><td>Polyneuropathy associated with underlying disease (G63)</td></tr><tr><th>Referral Organization</th><td>ClareMedica of Plaza Miami</td></tr><tr><th>Referring Provider First Name</th><td>MICHAEL</td></tr><tr><th>Referring Provider Last Name</th><td>CAVANAUGH</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider Specialty</th><td>Neurology</td></tr><tr><th>General Notes</th><td>Sanabria, Joannie 10/09/2024 01:31:14 PM &gt;referral already done and auth faxed too.</td></tr><tr><th>Referral Priority</th><td>Urgent</td></tr><tr><th>Referral Appointment Date</th><td>10/17/2024</td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>Patient presents here today for  his 2 month F/U, requesting a referral for Dr. Infante at Baptist, Also C/O having headaches, and requesting refills on all of his medications, Denies any recent ER or Urgent Care visits, also reviewed other chronic medical conditions: See Assessment (CL)</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Atorvastatin Calcium 20 MG</td><td ID="instruction1">1 tablet Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">hydrALAZINE HCl 100 MG</td><td ID="instruction2"><p>1 tablet with food Orally three times a day for 90 days</p><p>dc hydralazind 25mg tabs</p></td><td/><td>07/24/2024</td><td/><td>Active</td></tr><tr><td ID="medication3">glipiZIDE ER 10 MG</td><td ID="instruction3">1 tablet with breakfast Orally twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">metFORMIN HCl 500 MG</td><td ID="instruction4">take 1 tab at noon daily Orally Once a day</td><td/><td>06/26/2024</td><td/><td>Active</td></tr><tr><td ID="medication5">Carvedilol 12.5 MG</td><td ID="instruction5">TAKE 1 TABLET BY MOUTH TWICE DAILY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Lantus SoloStar 100 UNIT/ML</td><td ID="instruction6">INJECT 30 UNITS SUBCUTANEOUSLY ONCE DAILY for 84</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Labetalol HCl 200 MG</td><td ID="instruction7"><p>1 tablet Orally Twice a day for 90 days</p><p>dc labetolol 100mg</p></td><td/><td>10/09/2024</td><td/><td>Active</td></tr><tr><td ID="medication8">Testosterone Cypionate 200 MG/ML</td><td ID="instruction8">1 mL Intramuscular every 2 weeks for 90 days</td><td/><td>07/24/2024</td><td/><td>Active</td></tr><tr><td ID="medication9">Losartan Potassium-HCTZ 100-12.5 MG</td><td ID="instruction9">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Ozempic (2 MG/DOSE) 8 MG/3ML</td><td ID="instruction10">INJECT 2MG SUBCUTANEOUSLY ONCE A WEEK for 90 days</td><td/><td/><td>10/22/2024</td><td>Active</td></tr><tr><td ID="medication11">Pioglitazone HCl 45 MG</td><td ID="instruction11">TAKE 1 TABLET BY MOUTH EVERY DAY Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">metFORMIN HCl 1000 MG</td><td ID="instruction12">1 tablet with a meal ( 1 tab in the morning and 1 tab in the evening) Orally Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>nonsmoker</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>96.3 degrees Fahrenheit</td><td>10/09/2024</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>144 mm Hg</td><td>10/09/2024</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>70 mm Hg</td><td>10/09/2024</td></tr><tr><th ID="vital4">Heart Rate</th><td>70 /min</td><td>10/09/2024</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>18 /min</td><td>10/09/2024</td></tr><tr><th ID="vital6">Height</th><td>67 in</td><td>10/09/2024</td></tr><tr><th ID="vital7">Weight</th><td>225.0 lbs</td><td>10/09/2024</td></tr><tr><th ID="vital8">BMI</th><td>35.24 kg/m2</td><td>10/09/2024</td></tr><tr><th ID="vital9">Oximetry</th><td>95 %</td><td>10/09/2024</td></tr><tr><th ID="vital10">Height-cm</th><td>170.18 cm</td><td>10/09/2024</td></tr><tr><th ID="vital11">Weight-kg</th><td>102.06 kg</td><td>10/09/2024</td></tr><tr><td colspan="3"><span class="content_span">130/70</span></td></tr></tbody></table></div><h3><a name="id7" href="#toc">Procedures</a></h3><div><table width="100%" border="1"><thead><tr><th>Procedure</th><th>Date Ordered</th><th>Date Performed</th><th>Result</th><th>Body Site</th></tr></thead><tbody><tr><td ID="procedure1">ECHOCARDIOGRAM</td><td>10/09/2024</td><td/><td>N/A</td><td/></tr><tr><td ID="procedure2">Mini Mental Exam (MMSE)</td><td>10/09/2024</td><td/><td>N/A</td><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>ClareMedica of Plaza Miami</td><td>11211 SW 152ND ST MIAMI, FL 33157-1101</td><td>10/09/2024</td><td>MICHAEL CAVANAUGH</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Chronic kidney disease, stage 3a N18.31 ; Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene E11.51 ; Polyneuropathy associated with underlying disease G63 ; Degenerative disease of nervous system, unspecified G31.9 ; Dementia associated with other underlying disease without behavioral disturbance F02.80 ; Headache in front of head R51.9 ; Morbid (severe) obesity due to excess calories E66.01 ; Adult BMI 35.0-35.9 kg/sq m Z68.35 ; Encounter for screening for cardiovascular disorders Z13.6 and Encounter for screening examination for mental health and behavioral disorders, unspecified Z13.30</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">10/09/2024</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td>With CKD 3, BP within the acceptable range on Angiotensin receptor blocker, and Beta blocker, continue as prescribed.</td><td/><td>incred labetold to 200bid adnfu in 10days</td><td/></tr><tr><td ID="ref2">10/09/2024</td><td>Chronic kidney disease, stage 3a (ICD-10 - N18.31)</td><td>Based on decreased GFR values (45-59) as tested in labs 9/26/22, 1/10/22 and prior; currently improved.</td><td/><td/><td/></tr><tr><td ID="ref3">10/09/2024</td><td>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene (ICD-10 - E11.51)</td><td>PAD mild in the left leg indicated on Non-Invasive Peripheral Arterial Study 1/8/20.</td><td/><td/><td/></tr><tr><td ID="ref4">10/09/2024</td><td>Polyneuropathy associated with underlying disease (ICD-10 - G63)</td><td>Due to PVD</td><td/><td>longstndinpolynutopthydie todm</td><td/></tr><tr><td ID="ref5">10/09/2024</td><td>Degenerative disease of nervous system, unspecified (ICD-10 - G31.9)</td><td>Ventriculomegaly and prominence of the sulci, which is consistent with generalized atrophy, evident on Brain Imaging 8/26/20.</td><td/><td/><td/></tr><tr><td ID="ref6">10/09/2024</td><td>Dementia associated with other underlying disease without behavioral disturbance (ICD-10 - F02.80)</td><td>Based on Cerebral atrophy (CT Brain8/26/20.) as an important causal relationship for dementia.</td><td/><td>he heoa nothav demntia hehas brainatry by imagin noevidneof demnbtia</td><td/></tr><tr><td ID="ref7">10/09/2024</td><td>Headache in front of head (ICD-10 - R51.9)</td><td/><td/><td>hehs thisbizarre choenid ha onthe topod his skeull no sincutndernes had appt withneurollgy in 6 days willfu aftethattppt</td><td/></tr><tr><td ID="ref8">10/09/2024</td><td>Morbid (severe) obesity due to excess calories (ICD-10 - E66.01)</td><td>BMI of 34.77</td><td/><td>heisonozempic for his dma dnstilldifficult withwieght</td><td/></tr><tr><td ID="ref9">10/09/2024</td><td>Adult BMI 35.0-35.9 kg/sq m (ICD-10 - Z68.35)</td><td/><td/><td/><td/></tr><tr><td ID="ref10">10/09/2024</td><td>Encounter for screening for cardiovascular disorders (ICD-10 - Z13.6)</td><td/><td/><td/><td/></tr><tr><td ID="ref11">10/09/2024</td><td>Encounter for screening examination for mental health and behavioral disorders, unspecified (ICD-10 - Z13.30)</td><td/><td/><td/><td/></tr><tr><td ID="ref12">10/09/2024</td><td>Other</td><td/><td/><td>increainght labetol tocontrolthe bp</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Labetalol HCl 200 MG</td><td>1 tablet Orally Twice a day for 90 days</td><td>10/09/2024</td><td/><td/></tr></tbody></table><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">ECHOCARDIOGRAM</td><td>10/09/2024</td></tr><tr><td ID="pendingTest2">Mini Mental Exam (MMSE)</td><td>10/09/2024</td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">QuantaFlo</td><td>10/09/2024</td></tr></tbody></table><span class="content_span">Referrals</span><table width="100%" border="1"><thead><tr><th>Referral Date</th><th>Details</th></tr></thead><tbody><tr><td ID="referral1">10/09/2024</td><td>10/09/2024, dr lingante at baptisrt hehas anappointmenon on 10/17/24 | for mri.</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 10days, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:MICHAEL CAVANAUGH, 12/06/2024 01:40:00 PM, 11211 SW 152ND ST, MIAMI, FL, 33157-1101, 305-255-1355</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>GARCIA, RAUL <span class="bold">DOB:</span> 08/30/1951 (73 yo M) <span class="bold">Acc No.</span> 75377 <span class="bold">DOS:</span> 10/09/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>GARCIA, RAUL<br/><span class="bold">Account Number: </span>75377</td><td align="right"><span class="bold">Provider: </span>MICHAEL CAVANAUGH, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>08/30/1951<span class="bold">   Age: </span>73 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>10/09/2024</td></tr><tr><td><span class="bold">Phone: </span>305-310-0625</td></tr><tr><td colspan="2"><span class="bold">Address: </span>14611 SW 124TH PLACE, MIAMI, FL-33186</td></tr><tr><td colspan="2"><span class="bold">Structured Data: </span> MRA Deep Review Date : 09/19/2024; MRA- QR Review Date : 08/12/2024</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. Patient presents here today for  his 2 month F/U, requesting a referral for Dr. Infante at Baptist. 2. Also C/O having headaches, and requesting refills on all of his medications. 3. Denies any recent ER or Urgent Care visits, also reviewed other chronic medical conditions: See Assessment (CL). </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Consent</span>: <br/>       mr garcia had the ct angiofrm thismornig at baptist se do nothave rsult s yer.<br/><br/>he istilgetting afrontal head coontheoto of thelef tsideof his head everyt day<br/> <br/>thisisevery day dnheibp stays very high inthe rangof 140 to 150<br/><br/>hehas thisheadache and hypertenso<br/><br/>Hisfather inlaw has metastaic cancer adn thefamiy adnhis wife canot dal eithit.<br/><br/>hehs fuwithdrlinfantat baptis andhhed hes ctangiodoentoday<br/><br/>heistilgeting frontalha adnhis bpisstillhighat taime mitrirujnng140 to 150 atthisatime<br/><br/>wilincrse his labetold to 200bid from 100tid adncontineuhisothermeds.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      Change in appetite denies. Weakness denies. Physical Activity Level regular exercise.   <br/>   <span class="Underline">Ophthalmologic</span>: <br/>      Change in vision denies.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Chest pain denies. Cough denies. Shortness of breath denies. Shortness of breath with exertion denies. Sputum production denies.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Chest pain denies. Chest pain at rest denies. Chest pain with exertion denies. Claudication denies. Dizziness denies. Dyspnea on exertion denies. Fluid accumulation in the legs denies.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Arthritis / arthralgia denies. Back problems denies. Leg cramps denies. Limping gait denies.   <br/>   <span class="Underline">Skin</span>: <br/>      Changing moles denies. Hives denies. Itching denies. Skin cancer denies. Skin lesion(s) denies. Ulcerations denies.   <br/>   SEE HPI; OTHERWISE ALL SYSYTEMS NEGATIVE.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> Anemia, unspecified (resolved ), Type 2 diabetes mellitus with hyperglycemia (resolved ).</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> Denies Past Surgical History. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> Denies Past Hospitalization. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased. Mother: deceased. Son: alive. Daughter: alive. 3 son(s) . . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking <br/>         Tobacco use: <span class="italics">nonsmoker</span><br/>   <span class="Underline">Drugs/Alcohol:</span> <br/>       Caffeine <br/>         Intake: <span class="italics">1-2 cups per day</span><br/>      Do you smoke marijuana?: DENIES. <br/>      Do you drink alcohol?: Ocasionally. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking metFORMIN HCl 500 MG Tablet take 1 tab at noon daily Orally Once a day , Taking Carvedilol 12.5 MG Tablet TAKE 1 TABLET BY MOUTH TWICE DAILY   , Taking hydrALAZINE HCl 100 MG Tablet 1 tablet with food Orally three times a day dc hydralazind 25mg tabs, Taking glipiZIDE ER 10 MG Tablet Extended Release 24 Hour 1 tablet with breakfast Orally twice a day , Taking Atorvastatin Calcium 20 MG Tablet 1 tablet Oral Once a day , Taking Losartan Potassium-HCTZ 100-12.5 MG Tablet 1 tablet Orally Once a day , Taking Pioglitazone HCl 45 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY Oral Once a day , Taking metFORMIN HCl 1000 MG Tablet 1 tablet with a meal ( 1 tab in the morning and 1 tab in the evening) Orally Twice a day , Taking Ozempic (2 MG/DOSE) 8 MG/3ML Solution Pen-injector INJECT 2MG SUBCUTANEOUSLY ONCE A WEEK   , stop date 10/22/2024, Taking Testosterone Cypionate 200 MG/ML Solution 1 mL Intramuscular every 2 weeks , Taking Lantus SoloStar 100 UNIT/ML Solution Pen-injector INJECT 30 UNITS SUBCUTANEOUSLY ONCE DAILY   , Discontinued Labetalol HCl 100 MG Tablet 1 tablet Orally Three times a day , Discontinued hydrALAZINE HCl 25 MG Tablet 2 tablet with food Orally Three times a day dc amlodipine and nifedipine and flexeril, Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Prednisone  (10.00000 - mg): Allergy - Onset Date 01/08/2020. </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Temp: <span class="bold">96.3</span> F, HR: <span class="bold">70</span> /min, BP: <span class="bold">144/70</span> mm Hg, Ht: 67 in, Wt: <span class="bold">225.0</span> lbs, BMI: <span class="bold">35.24</span> Index, Oxygen sat %: <span class="bold">95</span> %, RR: <span class="bold">18</span> /min, Ht-cm: 170.18 cm, Wt-kg: 102.06 kg, Body Surface Area: 2.19.<br/><span class="content_span">130/70</span>.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, pleasant, well-nourished and in no acute distress. <br/>      Head: normocephalic, atraumatic. <br/>      Skin: skin is warm and dry, with no rashes, good skin turgor and normal hair distribution. <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Abdomen: soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly. <br/>      Neurologic: Alert and oriented x 3, deep tendon reflexes 2+ symmetrical, gait normal, normal upper and lower extremity motor strength and function. <br/>      Back: normal, without kyphoscoliosis or tenderness, full range of motion without difficulty. <br/>      Extremities: normal extremity with no clubbing, cyanosis or edema. <br/>      Psych: alert and oriented x 3. <br/>      Peripheral pulses: normal 2+ arterial pulses.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I12.9 (Primary)   <content><span class="bold">Notes : </span>With CKD 3, BP within the acceptable range on Angiotensin receptor blocker, and Beta blocker, continue as prescribed.</content>   2. Chronic kidney disease, stage 3a - N18.31   <content><span class="bold">Notes : </span>Based on decreased GFR values (45-59) as tested in labs 9/26/22, 1/10/22 and prior; currently improved.</content>   3. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene - E11.51   <content><span class="bold">Notes : </span>PAD mild in the left leg indicated on Non-Invasive Peripheral Arterial Study 1/8/20.</content>   4. Polyneuropathy associated with underlying disease - G63   <content><span class="bold">Notes : </span>Due to PVD</content>   5. Degenerative disease of nervous system, unspecified - G31.9   <content><span class="bold">Notes : </span>Ventriculomegaly and prominence of the sulci, which is consistent with generalized atrophy, evident on Brain Imaging 8/26/20.</content>   6. Dementia associated with other underlying disease without behavioral disturbance - F02.80   <content><span class="bold">Notes : </span>Based on Cerebral atrophy (CT Brain8/26/20.) as an important causal relationship for dementia.</content>   7. Headache in front of head - R51.9   8. Morbid (severe) obesity due to excess calories - E66.01   <content><span class="bold">Notes : </span>BMI of 34.77</content>   9. Adult BMI 35.0-35.9 kg/sq m - Z68.35   10. Encounter for screening for cardiovascular disorders - Z13.6   11. Encounter for screening examination for mental health and behavioral disorders, unspecified - Z13.30   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Start Labetalol HCl Tablet, 200 MG, 1 tablet, Orally, Twice a day dc labetolol 100mg, 90 days, 180 Tablet, Refills 3.  <br/>     <span class="Underline">Procedure: ECHOCARDIOGRAM</span><br/>Clinical Notes: incred labetold to 200bid adnfu in 10days  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Polyneuropathy associated with underlying disease</span> <br/>Clinical Notes: longstndinpolynutopthydie todm          <br/> Referral To:Neurology<br/>              Reason:dr lingante at baptisrt hehas anappointmenon on 10/17/24 | for mri.<br/></td></tr><tr><td/></tr><tr><td><span class="bold">3. Dementia associated with other underlying disease without behavioral disturbance</span> <br/>Clinical Notes: he heoa nothav demntia hehas brainatry by imagin noevidneof demnbtia  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Headache in front of head</span> <br/>Clinical Notes: hehs thisbizarre choenid ha onthe topod his skeull no sincutndernes had appt withneurollgy in 6 days willfu aftethattppt  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Morbid (severe) obesity due to excess calories</span> <br/>Clinical Notes: heisonozempic for his dma dnstilldifficult withwieght  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Encounter for screening for cardiovascular disorders</span> <br/>     <span class="Underline">Procedure: QuantaFlo (Ordered for 10/09/2024)</span></td></tr><tr><td/></tr><tr><td><span class="bold">7. Encounter for screening examination for mental health and behavioral disorders, unspecified</span> <br/>     <span class="Underline">Procedure: Mini Mental Exam (MMSE)</span></td></tr><tr><td/></tr><tr><td><span class="bold">8. Others </span> <br/>Clinical Notes: increainght labetol tocontrolthe bp  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 1159F MED LIST DOCD IN RCRD, 1160F RVW MEDS BY RX/DR IN RCRD, 3075F SYST BP GE 130 - 139MM HG, 3078F DIAST BP &lt;80 MM HG, 3008F BODY MASS INDEX DOCD, 2014F MENTAL STATUS ASSESS</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  QUALITY: <br/>       HEDIS Measures <br/>          Screening: <span class="italics">No falls in the past year</span><br/>          Date of last completed Functional Status Assessment: <span class="italics">03/06/2023</span><br/>          Functional Status <span class="italics">No impairment of functional status</span><br/>          Date of last Pain Assessment: <span class="italics">10/09/2024</span><br/>          Date of last Medication Review: <span class="italics">10/09/2024</span><br/>          Date of last Advance Care Planning: <span class="italics">06/27/2023</span><br/>          Last done Colonoscopy <span class="italics">10/12/2020 Pt is up to date with: Colonoscopy screening.</span><br/>          Most Recent HbA1c (Less then 9.0) <span class="italics">Controlled</span><br/>          Value <span class="italics">7.9</span><br/>          Date of Result <span class="italics">07-2024</span><br/>          Statin Use in Diabetic <span class="italics">Prescribed in MY</span><br/>          KED (eGFR &amp; uACR) <span class="italics">Addressed not closed.</span><br/>          Have you had an eye examination by an eye doctor? <span class="italics">Yes</span><br/>          Date of last dilated eye exam <span class="italics">03/04/2024</span><br/>          Specialty of provider who performed eye exam <span class="italics">Ophthalmologist</span><br/>          Last done diabetic foot exam <span class="italics">02/20/2024</span><br/>          PSA (Result and Date) <span class="italics"> PSA 1.1 on 07/31/2024</span><br/>          Last Flu Vaccine <span class="italics"> None On File</span><br/>          Mini Mental Exam (MMSE) <span class="italics">10/09/2024</span><br/>          EKG <span class="italics">04/05/2023</span><br/>          ECHO <span class="italics">02/19/2018 Ordered</span><br/>          PHQ9 <span class="italics">02/20/2024</span><br/>          QuantaFlo <span class="italics">12/14/2023 To be done next visit</span><br/>          Spirometry <span class="italics">Single</span><br/>          Date: <span class="italics">01/05/2017</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 10days</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>3075F SYST BP GE 130 - 139MM HG. <br/>3078F DIAST BP &lt;80 MM HG. <br/>3008F BODY MASS INDEX DOCD. <br/>2014F MENTAL STATUS ASSESS. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top">Electronically signed by MICHAEL CAVANAUGH , MD  on 10/15/2024 at 01:34 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> MICHAEL CAVANAUGH, MD</td><td align="right"><span class="bold">Date: </span>10/09/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 11/22/2024 12:02 PM EST</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id12" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td>Consent</td><td/><td colspan="2"/><td><p>mr garcia had the ct angiofrm thismornig at baptist se do nothave rsult s yer.</p><p>he istilgetting afrontal head coontheoto of thelef tsideof his head everyt day</p><p> </p><p>thisisevery day dnheibp stays very high inthe rangof 140 to 150</p><p>hehas thisheadache and hypertenso</p><p>Hisfather inlaw has metastaic cancer adn thefamiy adnhis wife canot dal eithit.</p><p>hehs fuwithdrlinfantat baptis andhhed hes ctangiodoentoday</p><p>heistilgeting frontalha adnhis bpisstillhighat taime mitrirujnng140 to 150 atthisatime</p><p>wilincrse his labetold to 200bid from 100tid adncontineuhisothermeds</p></td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="11">General Examination</td><td>General appearance:</td><td colspan="2">alert, pleasant, well-nourished and in no acute distress</td><td rowspan="11"/></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Abdomen:</td><td colspan="2">soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly</td></tr><tr><td>Neurologic:</td><td colspan="2">Alert and oriented x 3, deep tendon reflexes 2+ symmetrical, gait normal, normal upper and lower extremity motor strength and function</td></tr><tr><td>Skin:</td><td colspan="2">skin is warm and dry, with no rashes, good skin turgor and normal hair distribution</td></tr><tr><td>Extremities:</td><td colspan="2">normal extremity with no clubbing, cyanosis or edema</td></tr><tr><td>Peripheral pulses:</td><td colspan="2">normal 2+ arterial pulses</td></tr><tr><td>Back:</td><td colspan="2">normal, without kyphoscoliosis or tenderness, full range of motion without difficulty</td></tr><tr><td>Psych:</td><td colspan="2">alert and oriented x 3</td></tr></tbody></table><br/></li></ul></div><h3><a name="id13" href="#toc">Consultation Request Notes</a></h3><div><table width="100%" border="1"><tbody><tr><th>Referral Date</th><th>Referring Provider</th><th>Referred Provider</th><th>Notes</th></tr><tr ID="ConsultationNote1"><td>10/09/2024</td><td>CAVANAUGH, MICHAEL</td><td>, </td><td>dr lingante at baptisrt hehas anappointmenon on 10/17/24 | for mri.</td></tr></tbody></table></div><br/><br/></body></html>